Insider · CIK 0001721017

Goyal Vikas

Reports to the SEC for 3 companies · CONSHOHOCKEN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001721017

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-04-01	Pandion Therapeutics, Inc.U Disposition from Tender	See Remarks	UDisposition from Tender	−87.8K sh	$60.00	−$5.27M	0
2021-04-01	Pandion Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−28.2K sh	—	—	0
2021-04-01	Pandion Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−73.8K sh	—	—	0
2021-03-05	Morphic Holding, Inc.P Purchase	Director	PPurchase	+1,000 sh	$70.00	+$70K	1,000
2021-02-08	Pandion Therapeutics, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+73.8K sh	—	—	73,789
2020-07-21	Pandion Therapeutics, Inc.P Purchase	See Remarks	PPurchase	+1,450 sh	$18.00	+$26.1K	87,764
2020-07-21	Pandion Therapeutics, Inc.C Conversion	See Remarks	CConversion	+7,044 sh	—	—	86,314
2020-07-21	Pandion Therapeutics, Inc.Series B Preferred StockC Conversion	See Remarks	CConversion	−35.9K sh	—	—	0
2020-07-17	Pandion Therapeutics, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+13.9K sh	—	—	13,935
2020-07-17	Pandion Therapeutics, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+10.5K sh	—	—	10,486
2020-07-17	Pandion Therapeutics, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+3,806 sh	—	—	3,806
2020-06-18	Morphic Holding, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2019-08-01	Morphic Holding, Inc.Stock Option (right to buy Common Stock)A Award	Director	AAward	+24K sh	—	—	24,000
2019-07-01	Morphic Holding, Inc.C Conversion	Director	CConversion	+830K sh	—	—	2,300,439
2019-07-01	Morphic Holding, Inc.P Purchase	Director	PPurchase	+333K sh	$15.00	+$5M	2,633,772
2019-07-01	Morphic Holding, Inc.Series A Preferred StockC Conversion	Director	CConversion	−1.47M sh	—	—	0
2019-07-01	Morphic Holding, Inc.Series B Preferred StockC Conversion	Director	CConversion	−830K sh	—	—	0
2019-07-01	Morphic Holding, Inc.C Conversion	Director	CConversion	+1.47M sh	—	—	1,469,950
2017-11-06	SPROSpero Therapeutics, Inc. · Series A preferred stockC Conversion	Director	CConversion	−983K sh	—	—	0
2017-11-06	SPROSpero Therapeutics, Inc. · Series B preferred stockC Conversion	Director	CConversion	−1.25M sh	—	—	0
2017-11-06	SPROSpero Therapeutics, Inc. · Series C preferred stockC Conversion	Director	CConversion	−3.68M sh	—	—	0
2017-11-06	SPROSpero Therapeutics, Inc.C Conversion	Director	CConversion	+246K sh	—	—	490,419
2017-11-06	SPROSpero Therapeutics, Inc.C Conversion	Director	CConversion	+244K sh	—	—	244,147
2017-11-06	SPROSpero Therapeutics, Inc.C Conversion	Director	CConversion	+329K sh	—	—	819,411
2017-11-06	SPROSpero Therapeutics, Inc.C Conversion	Director	CConversion	+606K sh	—	—	1,425,435
2017-11-06	SPROSpero Therapeutics, Inc.P Purchase	Director	PPurchase	+429K sh	$14.00	+$6M	1,854,006
2017-11-06	SPROSpero Therapeutics, Inc. · Junior preferred stockC Conversion	Director	CConversion	−1.48M sh	—	—	0

Recent filings

Accepted (ET)
Apr 14
Goyal Vikas0000899243-21-014466
SEC(opens sec.gov)
Mar 84
Goyal Vikas0001209191-21-018758
SEC(opens sec.gov)
Feb 104
Goyal Vikas0000899243-21-005681
SEC(opens sec.gov)
Jul 214
Goyal Vikas0000899243-20-019873
SEC(opens sec.gov)
Jun 194
Goyal Vikas0001209191-20-038053
SEC(opens sec.gov)
Aug 24
Goyal Vikas0001179110-19-009026
SEC(opens sec.gov)
Jul 14
Goyal Vikas0001179110-19-008261
SEC(opens sec.gov)
Nov 74
Goyal Vikas0000899243-17-025508
SEC(opens sec.gov)

Companies

Address

C/O S.R. ONE, LIMITED 161 WASHINGTON STREET, SUITE 500

CONSHOHOCKEN, PA, 19428